RxBlog

Sponsor Media

Pages

RxBlog Resources

RxBlog Blogroll

  • Pfizer
    Our purpose is helping people live longer, healthier, happier lives. Our route to that purpose is through discovering and developing breakthrough medicines; providing information on prevention, wellness, and treatment.
  • Schering-Plough
    We aspire to earn the trust of doctors, patients and customers by providing a steady flow of innovative, science-based medicines and services that improve the health and well-being of people around the world.
  • Wyeth
    Wyeth pharmaceutical company brings health care products, medicines and vaccines that aim to improve lives and deliver value to customers.
  • Novartis
    Novartis is a world leader in offering medicines to protect health, cure disease and improve well-being. Our goal is to discover, develop and successfully market innovative products to treat patients, ease suffering and to enhance the quality of life.
  • GlaxoSmithKline
    Headquartered in the UK and with operations based in the US, we are one of the industry leaders, with an estimated seven per cent of the world's pharmaceutical market.
  • AstraZeneca
    One of the world's leading pharmaceutical companies providing effective prescription drugs and innovative prescription medicines in many important therapeutic areas.
  • Merck
    A global research-driven pharmaceutical company dedicated to putting patients first. Established in 1891, Merck discovers, develops, manufactures and markets vaccines and medicines to address unmet medical needs.

Sponsor Links


My Online Status

Recent Comments

Healthcare

Sponsor Video

Archives

Subscribe to my Podcast

Blogroll

Team unearths genetic risk factors for diabetes

Scientists have discovered three unsuspected regions of human DNA that contain clear genetic risk factors for type 2 diabetes, and another that is associated with elevated blood triglycerides.

Using this approach, the DGI team and their collaborators identified and confirmed three novel regions of the genome that influence the risk of type 2 diabetes, as well as a genomic region that is linked with blood triglyceride levels. Perhaps the most intriguing result involves a DNA region that lies far from any known annotated genes. Such genomic "outsiders" would have been incredibly difficult to find by traditional hypothesis-driven approaches.

» mit.edu / DGI [ Contribute: submit link / submit article / submit company ]

Posted at 02:52 PM in Rx Blog Diabetes | | Comments (0)

Stem cell cure hope for diabetes

Scientists have used stem cells from human bone marrow to repair defective insulin-producing pancreatic cells responsible for diabetes in mice. The treatment also halted damage to the kidneys caused by the condition. Researchers from New Orleans' Tulane University are hopeful it can be adapted to treat diabetes in humans.

» Search Healthcare-Specific Tags: Stem Cell Diabetes - Type 2 diabetes - Type 1 diabetes
» BBC News

Posted at 10:13 AM in Rx Blog Consumer, Rx Blog Diabetes | | Comments (0)

Novartis diabetes drug delayed

Novartis, the Swiss pharmaceutical company, on Monday said it had delayed approval by US regulators of Galvus, its new potential blockbuster diabetes drug Galvus by three months to allow submission of additional clinical data.

» Search Healthcare-Specific Tags: Novartis - Galvus

Posted at 11:16 AM in Rx Blog Diabetes, Rx Blog Investing, Rx Blog News | | Comments (0)